[go: up one dir, main page]
More Web Proxy on the site http://driver.im/

MA46513A - Nouvelle forme cristalline de 1,3-thiazol-5-ylméthyl[(2r,5r)-5-{[(2s)-2-[(méthyl{[2-(propan-2-yl)- 1,3-thiazol-4-yl]méthyl}carbamoyl)amino]-4-(morpholin-4-yl)butanoyl]amino}-1,6-diphénylhexan-2-yl]carbamate or cobicistat - Google Patents

Nouvelle forme cristalline de 1,3-thiazol-5-ylméthyl[(2r,5r)-5-{[(2s)-2-[(méthyl{[2-(propan-2-yl)- 1,3-thiazol-4-yl]méthyl}carbamoyl)amino]-4-(morpholin-4-yl)butanoyl]amino}-1,6-diphénylhexan-2-yl]carbamate or cobicistat

Info

Publication number
MA46513A
MA46513A MA046513A MA46513A MA46513A MA 46513 A MA46513 A MA 46513A MA 046513 A MA046513 A MA 046513A MA 46513 A MA46513 A MA 46513A MA 46513 A MA46513 A MA 46513A
Authority
MA
Morocco
Prior art keywords
thiazol
amino
methyl
diphenylhexan
cobicistat
Prior art date
Application number
MA046513A
Other languages
English (en)
Inventor
Armas Hector Novoa De
Chiajen Lai
Lok Him Lawrence Yu
Richard Hung Chiu Yu
Original Assignee
Gilead Sciences Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Gilead Sciences Inc filed Critical Gilead Sciences Inc
Publication of MA46513A publication Critical patent/MA46513A/fr

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing three or more hetero rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
    • C07D277/02—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
    • C07D277/20—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D277/22—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • C07D277/28—Radicals substituted by nitrogen atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/535—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines
    • A61K31/5375—1,4-Oxazines, e.g. morpholine
    • A61K31/5377—1,4-Oxazines, e.g. morpholine not condensed and containing further heterocyclic rings, e.g. timolol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/18—Antivirals for RNA viruses for HIV
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
    • C07B2200/00—Indexing scheme relating to specific properties of organic compounds
    • C07B2200/13—Crystalline forms, e.g. polymorphs

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Virology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Epidemiology (AREA)
  • Communicable Diseases (AREA)
  • Molecular Biology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • AIDS & HIV (AREA)
  • Oncology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Thiazole And Isothizaole Compounds (AREA)
  • Medicinal Preparation (AREA)
MA046513A 2016-01-28 2017-01-24 Nouvelle forme cristalline de 1,3-thiazol-5-ylméthyl[(2r,5r)-5-{[(2s)-2-[(méthyl{[2-(propan-2-yl)- 1,3-thiazol-4-yl]méthyl}carbamoyl)amino]-4-(morpholin-4-yl)butanoyl]amino}-1,6-diphénylhexan-2-yl]carbamate or cobicistat MA46513A (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US201662288029P 2016-01-28 2016-01-28

Publications (1)

Publication Number Publication Date
MA46513A true MA46513A (fr) 2019-08-21

Family

ID=57966186

Family Applications (1)

Application Number Title Priority Date Filing Date
MA046513A MA46513A (fr) 2016-01-28 2017-01-24 Nouvelle forme cristalline de 1,3-thiazol-5-ylméthyl[(2r,5r)-5-{[(2s)-2-[(méthyl{[2-(propan-2-yl)- 1,3-thiazol-4-yl]méthyl}carbamoyl)amino]-4-(morpholin-4-yl)butanoyl]amino}-1,6-diphénylhexan-2-yl]carbamate or cobicistat

Country Status (15)

Country Link
US (1) US20170217952A1 (fr)
EP (1) EP3408261A1 (fr)
JP (1) JP2019508393A (fr)
KR (1) KR20180101589A (fr)
CN (1) CN108834413A (fr)
AR (1) AR107441A1 (fr)
AU (2) AU2017211118B2 (fr)
BR (1) BR112018014643A2 (fr)
CA (1) CA3011930A1 (fr)
EA (1) EA201891447A1 (fr)
MA (1) MA46513A (fr)
MX (1) MX2018009056A (fr)
SG (1) SG11201806109RA (fr)
TW (1) TW201728582A (fr)
WO (1) WO2017132158A1 (fr)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
HUE026380T2 (en) 2008-05-02 2016-06-28 Gilead Sciences Inc Use of solid carrier particle
CN109384739B (zh) * 2017-08-14 2023-06-02 上海奥博生物医药股份有限公司 一种可比司他新晶型及其制备方法

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ME02258B (fr) 2006-07-07 2015-12-31 Gilead Sciences Inc Modulateurs de propriétés pharmacocinétiques d'agents thérapeutiques
HUE026380T2 (en) * 2008-05-02 2016-06-28 Gilead Sciences Inc Use of solid carrier particle
WO2012151165A1 (fr) * 2011-05-02 2012-11-08 Gilead Sciences, Inc. Sels solides amorphes

Also Published As

Publication number Publication date
AU2017211118B2 (en) 2020-01-16
US20170217952A1 (en) 2017-08-03
JP2019508393A (ja) 2019-03-28
SG11201806109RA (en) 2018-08-30
MX2018009056A (es) 2018-11-19
EA201891447A1 (ru) 2019-03-29
CA3011930A1 (fr) 2017-08-03
TW201728582A (zh) 2017-08-16
WO2017132158A1 (fr) 2017-08-03
BR112018014643A2 (pt) 2018-12-11
CN108834413A (zh) 2018-11-16
AR107441A1 (es) 2018-05-02
EP3408261A1 (fr) 2018-12-05
AU2019283825A1 (en) 2020-01-16
AU2017211118A1 (en) 2018-08-09
KR20180101589A (ko) 2018-09-12

Similar Documents

Publication Publication Date Title
IL267693A (en) N-[4-fluoro-5-[[(2S,4S)-2-methyl-4-[(5-methyl-1,2,4-oxadiazol-3-yl)methoxy]-1-piperidyl]methyl] Thiazol-2-yl]acetamide as an inhibitor of OGA
NO2022023I1 (no) Ponesimod (IUPAC name: (R)-5-[3-chloro-4-(2,3-dih ydroxy-propoxy)-benz[Z]ylidene]-2-([Z]-propylimino)-3-o-tolylthiazolidin-4-one) and harmaceutically acceptable salts thereof
AR116394A2 (es) Mesilato de n-[5-(aminosulfonil)-4-metil-1,3-tiazol-2-il]-n-metil-2-[4-(2-piridinil)fenil]acetamida monohidrato
BR112017004673A2 (pt) formas cristalinas de 2-(4-(4-etoxi-6-oxo-1,6-diidropiridin-3-ila)-2-fluorofenil)-n-(5-(1,1,1-trifluoro-2-metilpropan-2-il)isoxazol-3-il) acetamida
CL2016001918A1 (es) Heteroaril amidas como inhibidores de agregación de proteína
MA56383A (fr) Analogues de3-(5-méthyl-1,3-thiazol-2-yl)-n-((1r)-1-[2-(trifluoro-méthyl)pyrimidin-5-yl]éthyl)benzamide
MA46513A (fr) Nouvelle forme cristalline de 1,3-thiazol-5-ylméthyl[(2r,5r)-5-{[(2s)-2-[(méthyl{[2-(propan-2-yl)- 1,3-thiazol-4-yl]méthyl}carbamoyl)amino]-4-(morpholin-4-yl)butanoyl]amino}-1,6-diphénylhexan-2-yl]carbamate or cobicistat
HUE054845T2 (hu) Az N-[5-(amino-szulfonil)-4-metil-1,3-tiazol-2-il]-N-metil-2-[4-(2-piridinil)fenil]acetamid szabad bázis maleát sója, gyógyászati készítmények, elõállítási eljárások és Herpes vírusok kezelésére történõ alkalmazások
EP3638241A4 (fr) Formulations pharmaceutiques de n-(2-(2-(diméthylamino)éthoxy)-4-méthoxy-5-((4-(1-méthyl-1h-indole-3-yl)pyrimidine-2-yl)amino)phényl)acrylamide et de sels de ce dernier
IT201900021393A1 (it) Macchina confezionatrice e metodo di confezionamento per la produzione di cartucce monouso
EP3259267A4 (fr) Nouveau procédé de préparation de carbamate de 1,3-thiazol-5-ylméthyl[(2r,5r)-5-{[(2s)-2-[(méthyl{[2-(propan-2-yl)- 1,3-thiazol-4-yl]méthyl}carbamoyl)amino]-4-(morpholin-4-yl)butanoyl]amino}-1,6-diphénylhexan-2-yle]
EP3302466A4 (fr) Composés 3- (phényl)-n- (4-phénoxybenzyl) -1,2,4-oxadiazole-5-carboxamide pour la prise en charge de maladies médiées par la protéine cftr
IL263619A (en) Pharmaceutical salts of n-(2-(2-(dimethylamino)ethoxy)-4-methoxy-5-((4-(1-methyl-1h-indol-3-yl)pyrimidin-2-yl)amino)phenyl)acrylamide and crystalline forms thereof
IL283843A (en) (s)-n-hydroxy-2-(2-(4-methoxyphenyl)butanamido)thiazole-5-carboxamide and its pharmaceutically acceptable salts
CL2007002020A1 (es) Sal xinafoato del etil ester de la 1-[[5-(1(s)-aminoetil)-2-[8-metoxi-2-(trifluorometil)-5-quinolil]-4-oxazolil]carbonil]-4(r)-[(ciclopropil-carbonil)amino]-l-prolina; polimorfo cristalino; proceso de preparacion; composicion farmaceutica; y uso para
IT201900021405A1 (it) Macchina confezionatrice e metodo di confezionamento per la produzione di cartucce monouso
BR112018077250A2 (pt) processo de preparação de um inibidor de imunoproteassoma de epoxicetona peptídica e precursores dos mesmos
IL272034B (en) Process for preparing n-((1r, 2s, 5r)-5-(tert-butylamino)-2-((s)-3-(7-tert-butylpyrazolo[1,a-5][1, 3, 5) Triazine-4-ylamino)-2-oxopyrrolidin-1-yl)cyclohexyl)acetamide
RU2016146594A (ru) Средство для лечения деменции различной этиологии
IT201900021378A1 (it) Macchina confezionatrice e metodo di confezionamento per la produzione di cartucce monouso
IT201900021369A1 (it) Macchina confezionatrice e metodo di confezionamento per la produzione di cartucce monouso
IL264708B (en) History of n-[2-(4-phenoxypiperidin-1-yl)-2-(3,1-thiazol-5-yl)ethyl]benzamide and n-[2-(4-benzyloxypiperidin-1-yl)-2- (3,1-thiazol-5-yl)ethyl]benzamide-modified p2x7 receptor antagonists
WO2017143112A3 (fr) Oxazolidinone pour le traitement d'infections par un bacille de la tuberculose
DK3164385T3 (da) Ny polymorf form af n-[2-(6-fluor-lh-indol-3-yl)ethyl]-3-(2,2,3,3-tetrafluorpropoxy)benzylaminhydrochlorid for behandlingen af alzheimers
IT201900021381A1 (it) Macchina confezionatrice e metodo di confezionamento per la produzione di cartucce monouso